Results showed that CI-1040 significantly inhibited NB cell proliferation in both MYCN -amplified and -non-amplified cell lines in a dose-dependent manner and has minimal effect on normal non-cancerous fibroblast cell lines (Figure 3A–C). The gene discussed is MYCN; the disease is neuroblastoma.